Dr Eleni Glarou

Research interests: #autism #communication #discourseanalysis #systematicreviews #metanalysis #HTA • @CTRCardiffUni • @healthtechwales

[Dr Eleni Glarou @eleniglarou]

Our #paper on how rapport is built between #autistic children and occupational therapists in #SIT sessions is now published in SSM–Qualitative Research in Health @ElsevierConnect.
🔗 https://t.co/cjdjDiNHXI
@CTRCardiffUni @SenITA_Study @LBrookesHowell @McNamar13 @LizbethRandell

[Dr Eleni Glarou @eleniglarou]

Just #published in @NatMentHealth: Clozapine works best early!
• 81% response in non‑TRS
• 63% in TRS

❗️Drops from >90% at onset to ~46% by year 10

💡Early use may improve outcomes; chronic patients can still benefit

https://t.co/uGAU8mKzVp

@myrto_samara
@ElizPnt
@SiafisS

[Health Technology Wales @HealthTechWales]

Our researchers worked with the @ResearchWales Evidence Centre on a rapid review of the impact of medical tourism on the NHS. The findings show there is a burden on the NHS from treating patients with complications from medical tourism: https://t.co/eTvaG0UNyz

[Dr Eleni Glarou @eleniglarou]

Thrilled to see another piece of our work #published! I’m really proud of the talented team I collaborated with during my previous role- this was a great project to be part of. 🙏

[elisavet_pinioti @ElizPnt]

🚨 New publication alert!
It’s time for an updated and comprehensive meta-analysis comparing the safety of clozapine — both as monotherapy and in combination with other antipsychotics.
Proud to see our work published in The British Journal of Psychiatry! https://t.co/Ca59JtThe2

[Health Technology Wales @HealthTechWales]

Visit our stand at the @mediwales Showcase event tomorrow to find how we appraise health technologies and publish national guidance on their use in Wales

[Health Technology Wales @HealthTechWales]

We’re pleased to announce the publication of our latest Annual Report. Find out how we’ve made an impact in 2024/25 here: https://t.co/tmdqoHCnsk

[Dr Eleni Glarou @eleniglarou]

3/
💡 Big picture:
Treatment should be personalized
We need more high-quality RCTs - specially on non-clozapine strategies and long-term outcomes
Until then, clozapine is still king 👑
#Schizophrenia #Psychiatry #TRS #eClinicalMedicine #MetaAnalysis

[Dr Eleni Glarou @eleniglarou]

1/
📢 Just published in eClinicalMedicine!
We reviewed 150 RCTs (11,375 patients) to compare pharmacological treatments for treatment-resistant schizophrenia.
🔗 https://t.co/iqdKKtgGz3
@myrto_samara
@LeuchtStefan
@ElizPnt
@IwoFober
@SiafisS
@dimi_mavridis

[Dr Eleni Glarou @eleniglarou]

2/
🔍 Key findings:
🥇 Clozapine remains the gold standard
💊 Some clozapine combos (e.g., with amisulpride, duloxetine, or memantine) may enhance symptom control
🤔 Non-clozapine combos? Promising but under-studied
📊 Overall, antipsychotic combinations outperform monotherapy

[Lucy Brookes-Howell @LBrookesHowell]

In the UK or Ireland and involved in #qualitativeresearch in #RCTs? Please consider taking part in our survey to better understand qualitative researchers’ experiences
https://t.co/8W1GZnQp8s
@MRCNIHRTMRP @Methodology_Inc

[Dr Eleni Glarou @eleniglarou]

#New #systematic #review and #network #metanalysis focusing on all #pharmacotherapy options for sleep disturbance in #PTSD.

@CTRCardiffUni

Available here: https://t.co/BCdN5sp4re

[Dr Eleni Glarou @eleniglarou]

#New #paper describing the process through which #qualitative #research has been integrated within @CTRCardiffUni unit in Wales, UK.

@DrJeremySegrott
@josie_henley
@MilosevicSarah
@YvonneCMoriarty
@BethanPell
@StrangeHeather
@DaveGuk87
@VickyLShepherd
@LBrookesHowell

[General Medicine and Medical Evidence @ BMC @MedicalEvidence]

Integrating qualitative research within a clinical trials unit: developing strategies and understanding their implementation in contexts https://t.co/zvnRNw5pCQ

[Dr Eleni Glarou @eleniglarou]

@PicklesTim Congratulations Tim!! Well deserved 🙏🏻

[Sarah Milosevic @MilosevicSarah]

Our qualitative paper on the rehabilitation experiences of lower limb amputees, from the PLACEMENT Feasibility Trial, has been published in @DisabilityRehab
https://t.co/9JZ50AeLar
PM me if you'd like a link to a free eprint!

[Sarah Milosevic @MilosevicSarah]

Pleased to hear our @SenITA_Study paper highlighting experiences and unmet support needs of families of children with #autism and #sensoryprocessingdifficulties was one of last year's #TopDownloadedArticles in Health Expectations https://t.co/elLh2emdQ2

[⚫ Zoë Abbott (she / her) @ZoeAbbott83]

Super excited to learn Dr @eleniglarou is coming back to @DPMRes, @cardiffuni to talk to us about her work with multi-party #communication in #therapy sessions with #Autistic #children, next week! Missed you Eleni! Looking forward to hearing you talk 😊🤓🫶🏻

[Dr Eleni Glarou @eleniglarou]

@ZoeAbbott83 Thank you so much for the support, Zoe! I am really excited to share the results of my PhD revealing how communication unfolds between autistic children and OTs during therapeutic sessions. 🙌🏻🙌🏻🙌🏻

[Dr Eleni Glarou @eleniglarou]

#New #SenITA paper exploring critical intervention features & trial processes in the evaluation of #SIT for #autistic children.

@SenITA_Study
@CTRCardiffUni
@LizbethRandell
@McNamar13
@DaveGuk87
@MilosevicSarah
@LBrookesHowell
@ProfRHastings
@AlkaSashin

[ISRCTN: the UK's Clinical Study Registry @ISRCTN]

Exploring critical intervention features and trial processes in the evaluation of sensory integration therapy for autistic children

Read the results published in #TrialsJournal @‌MedicalEvidence

#ISRCTN: https://t.co/pkVe89GRYJ

https://t.co/xseXB50d8p

[Dr Eleni Glarou @eleniglarou]

#New systematic review and metanalysis of questionnaires used for #auditoryprocessing screening and evaluation.

https://t.co/6flheUVKcK

@samara_myrto
@CTRCardiffUni
@DPMRes
@ucl
@uth_gr